L-ornitina L-aspartato para pacientes con enfermedad hepática crónica y encefalopatía hepática (funcionamiento cerebral deficiente) https://t.co/2KhJlFH54R
hepa ce?! https://t.co/8QyROXKLQU
#LOLA is beneficial in comparison with #placebo for treating #hepatic encephalopathy... Need for more evidence!? L-ornithine L-aspartate for prevention and treatment of hepatic... https://t.co/3ygXapxQSI
RT @CochraneUK: New @cochranecollab review from Cochrane Hepato-Biliary - L-ornithine L-aspartate for prevention and treatment of hepatic e…
RT @Abraham_RMI: Conclusion: Very low evidence to recommend treatment with L-ornithine L-aspartate for prevention and treatment of hepatic…
Conclusion: Very low evidence to recommend treatment with L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis CC @giordanopg @OjinoSosa @VinayPrasadMD @adamcifu @medevidenceblog https://t.co/JpDhg6n0Hm
RT @CochraneLibrary: New @cochranecollab review from Cochrane Hepato-Biliary - L-ornithine L-aspartate for prevention and treatment of hepa…
New @cochranecollab review from Cochrane Hepato-Biliary - L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with #cirrhosis https://t.co/WgMVCHgGpd https://t.co/NcrxrePMpv